Pfizer takes aim at BMS' first-in-class Zeposia with FDA nod for ulcerative colitis drug Velsipity

13th October 2023 Uncategorised 0

Pfizer takes aim at BMS’ first-in-class Zeposia with FDA nod for ulcerative colitis drug Velsipity
aliu
Fri, 10/13/2023 – 09:01

More: Pfizer takes aim at BMS' first-in-class Zeposia with FDA nod for ulcerative colitis drug Velsipity
Source: fierce